Cell Therapy

The clinical landscape for advanced medicine reached a definitive turning point on May 8, 2026, when Guy’s and St Thomas’ NHS Foundation Trust successfully completed its first inspection under the 3rd Edition Immune Effector Cells Standards. This milestone represents a significant departure from

The recent validation of Rimcato-joo by the Ministry of Food and Drug Safety represents a seismic shift in South Korea’s medical landscape, proving that domestic firms can move beyond manufacturing biosimilars into the high-stakes arena of personalized genetic medicine. For years, the local biotech

Ivan Kairatov is a distinguished expert in the biopharmaceutical sector, recognized for his deep specialization in research and development and the integration of innovative technologies in cancer care. His work frequently bridges the gap between complex bioengineering and clinical application,

The ALARIC clinical trial represents a monumental leap forward in the treatment of light chain amyloidosis, marking the first time that European researchers have utilized Chimeric Antigen Receptor (CAR) T-cell therapy for this specific patient population. Led by a collaborative team from University

The effectiveness of a human's internal defense system might rely more on the timing of their last meal than previously understood by modern clinical science. While scientific inquiry has traditionally focused on how chronic nutritional states, such as long-term obesity or persistent malnutrition,

The clinical landscape of oncology shifted dramatically with the birth of cellular engineering, yet the early excitement often masked a persistent struggle against the rapid exhaustion of the very tools designed to save lives. While Chimeric Antigen Receptor (CAR) T-cell therapy has achieved